Global Butorphanol Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Butorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans.
LPI (LP Information)' newest research report, the “Butorphanol Industry Forecast” looks at past sales and reviews total world Butorphanol sales in 2022, providing a comprehensive analysis by region and market sector of projected Butorphanol sales for 2023 through 2029. With Butorphanol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Butorphanol industry.
This Insight Report provides a comprehensive analysis of the global Butorphanol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Butorphanol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Butorphanol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Butorphanol and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Butorphanol.
The global Butorphanol market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Butorphanol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Butorphanol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Butorphanol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Butorphanol players cover Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika and Selectavet, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Butorphanol market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Butorphanol market?
What factors are driving Butorphanol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Butorphanol market opportunities vary by end market size?
How does Butorphanol break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Butorphanol is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers. Butorphanol is available as the tartrate salt in injectable, tablet, and intranasal spray formulations. The tablet form is only used in dogs, cats and horses due to low bioavailability in humans.
LPI (LP Information)' newest research report, the “Butorphanol Industry Forecast” looks at past sales and reviews total world Butorphanol sales in 2022, providing a comprehensive analysis by region and market sector of projected Butorphanol sales for 2023 through 2029. With Butorphanol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Butorphanol industry.
This Insight Report provides a comprehensive analysis of the global Butorphanol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Butorphanol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Butorphanol market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Butorphanol and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Butorphanol.
The global Butorphanol market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Butorphanol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Butorphanol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Butorphanol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Butorphanol players cover Hikma Pharmaceuticals, Athanas Enterprise Private Limited, Pfizer, Apothecon Pharmaceuticals, Mylan, Novex Pharma, Bristol Myers Squibb, Sanochemia Pharmazeutika and Selectavet, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Butorphanol market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Spray
- Injection
- Tablet
- Human
- Veterinary
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Hikma Pharmaceuticals
- Athanas Enterprise Private Limited
- Pfizer
- Apothecon Pharmaceuticals
- Mylan
- Novex Pharma
- Bristol Myers Squibb
- Sanochemia Pharmazeutika
- Selectavet
- Richter Pharma Ag
- Troy Laboratories Nz
- Animedica
- Boehringer Ingelheim Sant? Animale
- Ausrichter
- Zoetis
- Dechra Pharmaceuticals
- Faunapharma
- Merck KGaA
What is the 10-year outlook for the global Butorphanol market?
What factors are driving Butorphanol market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Butorphanol market opportunities vary by end market size?
How does Butorphanol break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Butorphanol Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Butorphanol by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Butorphanol by Country/Region, 2018, 2022 & 2029
2.2 Butorphanol Segment by Type
2.2.1 Spray
2.2.2 Injection
2.2.3 Tablet
2.3 Butorphanol Sales by Type
2.3.1 Global Butorphanol Sales Market Share by Type (2018-2023)
2.3.2 Global Butorphanol Revenue and Market Share by Type (2018-2023)
2.3.3 Global Butorphanol Sale Price by Type (2018-2023)
2.4 Butorphanol Segment by Application
2.4.1 Human
2.4.2 Veterinary
2.5 Butorphanol Sales by Application
2.5.1 Global Butorphanol Sale Market Share by Application (2018-2023)
2.5.2 Global Butorphanol Revenue and Market Share by Application (2018-2023)
2.5.3 Global Butorphanol Sale Price by Application (2018-2023)
3 GLOBAL BUTORPHANOL BY COMPANY
3.1 Global Butorphanol Breakdown Data by Company
3.1.1 Global Butorphanol Annual Sales by Company (2018-2023)
3.1.2 Global Butorphanol Sales Market Share by Company (2018-2023)
3.2 Global Butorphanol Annual Revenue by Company (2018-2023)
3.2.1 Global Butorphanol Revenue by Company (2018-2023)
3.2.2 Global Butorphanol Revenue Market Share by Company (2018-2023)
3.3 Global Butorphanol Sale Price by Company
3.4 Key Manufacturers Butorphanol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Butorphanol Product Location Distribution
3.4.2 Players Butorphanol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BUTORPHANOL BY GEOGRAPHIC REGION
4.1 World Historic Butorphanol Market Size by Geographic Region (2018-2023)
4.1.1 Global Butorphanol Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Butorphanol Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Butorphanol Market Size by Country/Region (2018-2023)
4.2.1 Global Butorphanol Annual Sales by Country/Region (2018-2023)
4.2.2 Global Butorphanol Annual Revenue by Country/Region (2018-2023)
4.3 Americas Butorphanol Sales Growth
4.4 APAC Butorphanol Sales Growth
4.5 Europe Butorphanol Sales Growth
4.6 Middle East & Africa Butorphanol Sales Growth
5 AMERICAS
5.1 Americas Butorphanol Sales by Country
5.1.1 Americas Butorphanol Sales by Country (2018-2023)
5.1.2 Americas Butorphanol Revenue by Country (2018-2023)
5.2 Americas Butorphanol Sales by Type
5.3 Americas Butorphanol Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Butorphanol Sales by Region
6.1.1 APAC Butorphanol Sales by Region (2018-2023)
6.1.2 APAC Butorphanol Revenue by Region (2018-2023)
6.2 APAC Butorphanol Sales by Type
6.3 APAC Butorphanol Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Butorphanol by Country
7.1.1 Europe Butorphanol Sales by Country (2018-2023)
7.1.2 Europe Butorphanol Revenue by Country (2018-2023)
7.2 Europe Butorphanol Sales by Type
7.3 Europe Butorphanol Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Butorphanol by Country
8.1.1 Middle East & Africa Butorphanol Sales by Country (2018-2023)
8.1.2 Middle East & Africa Butorphanol Revenue by Country (2018-2023)
8.2 Middle East & Africa Butorphanol Sales by Type
8.3 Middle East & Africa Butorphanol Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Butorphanol
10.3 Manufacturing Process Analysis of Butorphanol
10.4 Industry Chain Structure of Butorphanol
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Butorphanol Distributors
11.3 Butorphanol Customer
12 WORLD FORECAST REVIEW FOR BUTORPHANOL BY GEOGRAPHIC REGION
12.1 Global Butorphanol Market Size Forecast by Region
12.1.1 Global Butorphanol Forecast by Region (2024-2029)
12.1.2 Global Butorphanol Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Butorphanol Forecast by Type
12.7 Global Butorphanol Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hikma Pharmaceuticals
13.1.1 Hikma Pharmaceuticals Company Information
13.1.2 Hikma Pharmaceuticals Butorphanol Product Portfolios and Specifications
13.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hikma Pharmaceuticals Main Business Overview
13.1.5 Hikma Pharmaceuticals Latest Developments
13.2 Athanas Enterprise Private Limited
13.2.1 Athanas Enterprise Private Limited Company Information
13.2.2 Athanas Enterprise Private Limited Butorphanol Product Portfolios and Specifications
13.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Athanas Enterprise Private Limited Main Business Overview
13.2.5 Athanas Enterprise Private Limited Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Butorphanol Product Portfolios and Specifications
13.3.3 Pfizer Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Apothecon Pharmaceuticals
13.4.1 Apothecon Pharmaceuticals Company Information
13.4.2 Apothecon Pharmaceuticals Butorphanol Product Portfolios and Specifications
13.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Apothecon Pharmaceuticals Main Business Overview
13.4.5 Apothecon Pharmaceuticals Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Butorphanol Product Portfolios and Specifications
13.5.3 Mylan Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Novex Pharma
13.6.1 Novex Pharma Company Information
13.6.2 Novex Pharma Butorphanol Product Portfolios and Specifications
13.6.3 Novex Pharma Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novex Pharma Main Business Overview
13.6.5 Novex Pharma Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Butorphanol Product Portfolios and Specifications
13.7.3 Bristol Myers Squibb Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Sanochemia Pharmazeutika
13.8.1 Sanochemia Pharmazeutika Company Information
13.8.2 Sanochemia Pharmazeutika Butorphanol Product Portfolios and Specifications
13.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanochemia Pharmazeutika Main Business Overview
13.8.5 Sanochemia Pharmazeutika Latest Developments
13.9 Selectavet
13.9.1 Selectavet Company Information
13.9.2 Selectavet Butorphanol Product Portfolios and Specifications
13.9.3 Selectavet Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Selectavet Main Business Overview
13.9.5 Selectavet Latest Developments
13.10 Richter Pharma Ag
13.10.1 Richter Pharma Ag Company Information
13.10.2 Richter Pharma Ag Butorphanol Product Portfolios and Specifications
13.10.3 Richter Pharma Ag Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Richter Pharma Ag Main Business Overview
13.10.5 Richter Pharma Ag Latest Developments
13.11 Troy Laboratories Nz
13.11.1 Troy Laboratories Nz Company Information
13.11.2 Troy Laboratories Nz Butorphanol Product Portfolios and Specifications
13.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Troy Laboratories Nz Main Business Overview
13.11.5 Troy Laboratories Nz Latest Developments
13.12 Animedica
13.12.1 Animedica Company Information
13.12.2 Animedica Butorphanol Product Portfolios and Specifications
13.12.3 Animedica Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Animedica Main Business Overview
13.12.5 Animedica Latest Developments
13.13 Boehringer Ingelheim Sant? Animale
13.13.1 Boehringer Ingelheim Sant? Animale Company Information
13.13.2 Boehringer Ingelheim Sant? Animale Butorphanol Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Sant? Animale Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Boehringer Ingelheim Sant? Animale Main Business Overview
13.13.5 Boehringer Ingelheim Sant? Animale Latest Developments
13.14 Ausrichter
13.14.1 Ausrichter Company Information
13.14.2 Ausrichter Butorphanol Product Portfolios and Specifications
13.14.3 Ausrichter Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ausrichter Main Business Overview
13.14.5 Ausrichter Latest Developments
13.15 Zoetis
13.15.1 Zoetis Company Information
13.15.2 Zoetis Butorphanol Product Portfolios and Specifications
13.15.3 Zoetis Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Zoetis Main Business Overview
13.15.5 Zoetis Latest Developments
13.16 Dechra Pharmaceuticals
13.16.1 Dechra Pharmaceuticals Company Information
13.16.2 Dechra Pharmaceuticals Butorphanol Product Portfolios and Specifications
13.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Dechra Pharmaceuticals Main Business Overview
13.16.5 Dechra Pharmaceuticals Latest Developments
13.17 Faunapharma
13.17.1 Faunapharma Company Information
13.17.2 Faunapharma Butorphanol Product Portfolios and Specifications
13.17.3 Faunapharma Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Faunapharma Main Business Overview
13.17.5 Faunapharma Latest Developments
13.18 Merck KGaA
13.18.1 Merck KGaA Company Information
13.18.2 Merck KGaA Butorphanol Product Portfolios and Specifications
13.18.3 Merck KGaA Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Merck KGaA Main Business Overview
13.18.5 Merck KGaA Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Butorphanol Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Butorphanol by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Butorphanol by Country/Region, 2018, 2022 & 2029
2.2 Butorphanol Segment by Type
2.2.1 Spray
2.2.2 Injection
2.2.3 Tablet
2.3 Butorphanol Sales by Type
2.3.1 Global Butorphanol Sales Market Share by Type (2018-2023)
2.3.2 Global Butorphanol Revenue and Market Share by Type (2018-2023)
2.3.3 Global Butorphanol Sale Price by Type (2018-2023)
2.4 Butorphanol Segment by Application
2.4.1 Human
2.4.2 Veterinary
2.5 Butorphanol Sales by Application
2.5.1 Global Butorphanol Sale Market Share by Application (2018-2023)
2.5.2 Global Butorphanol Revenue and Market Share by Application (2018-2023)
2.5.3 Global Butorphanol Sale Price by Application (2018-2023)
3 GLOBAL BUTORPHANOL BY COMPANY
3.1 Global Butorphanol Breakdown Data by Company
3.1.1 Global Butorphanol Annual Sales by Company (2018-2023)
3.1.2 Global Butorphanol Sales Market Share by Company (2018-2023)
3.2 Global Butorphanol Annual Revenue by Company (2018-2023)
3.2.1 Global Butorphanol Revenue by Company (2018-2023)
3.2.2 Global Butorphanol Revenue Market Share by Company (2018-2023)
3.3 Global Butorphanol Sale Price by Company
3.4 Key Manufacturers Butorphanol Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Butorphanol Product Location Distribution
3.4.2 Players Butorphanol Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BUTORPHANOL BY GEOGRAPHIC REGION
4.1 World Historic Butorphanol Market Size by Geographic Region (2018-2023)
4.1.1 Global Butorphanol Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Butorphanol Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Butorphanol Market Size by Country/Region (2018-2023)
4.2.1 Global Butorphanol Annual Sales by Country/Region (2018-2023)
4.2.2 Global Butorphanol Annual Revenue by Country/Region (2018-2023)
4.3 Americas Butorphanol Sales Growth
4.4 APAC Butorphanol Sales Growth
4.5 Europe Butorphanol Sales Growth
4.6 Middle East & Africa Butorphanol Sales Growth
5 AMERICAS
5.1 Americas Butorphanol Sales by Country
5.1.1 Americas Butorphanol Sales by Country (2018-2023)
5.1.2 Americas Butorphanol Revenue by Country (2018-2023)
5.2 Americas Butorphanol Sales by Type
5.3 Americas Butorphanol Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Butorphanol Sales by Region
6.1.1 APAC Butorphanol Sales by Region (2018-2023)
6.1.2 APAC Butorphanol Revenue by Region (2018-2023)
6.2 APAC Butorphanol Sales by Type
6.3 APAC Butorphanol Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Butorphanol by Country
7.1.1 Europe Butorphanol Sales by Country (2018-2023)
7.1.2 Europe Butorphanol Revenue by Country (2018-2023)
7.2 Europe Butorphanol Sales by Type
7.3 Europe Butorphanol Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Butorphanol by Country
8.1.1 Middle East & Africa Butorphanol Sales by Country (2018-2023)
8.1.2 Middle East & Africa Butorphanol Revenue by Country (2018-2023)
8.2 Middle East & Africa Butorphanol Sales by Type
8.3 Middle East & Africa Butorphanol Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Butorphanol
10.3 Manufacturing Process Analysis of Butorphanol
10.4 Industry Chain Structure of Butorphanol
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Butorphanol Distributors
11.3 Butorphanol Customer
12 WORLD FORECAST REVIEW FOR BUTORPHANOL BY GEOGRAPHIC REGION
12.1 Global Butorphanol Market Size Forecast by Region
12.1.1 Global Butorphanol Forecast by Region (2024-2029)
12.1.2 Global Butorphanol Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Butorphanol Forecast by Type
12.7 Global Butorphanol Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Hikma Pharmaceuticals
13.1.1 Hikma Pharmaceuticals Company Information
13.1.2 Hikma Pharmaceuticals Butorphanol Product Portfolios and Specifications
13.1.3 Hikma Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Hikma Pharmaceuticals Main Business Overview
13.1.5 Hikma Pharmaceuticals Latest Developments
13.2 Athanas Enterprise Private Limited
13.2.1 Athanas Enterprise Private Limited Company Information
13.2.2 Athanas Enterprise Private Limited Butorphanol Product Portfolios and Specifications
13.2.3 Athanas Enterprise Private Limited Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Athanas Enterprise Private Limited Main Business Overview
13.2.5 Athanas Enterprise Private Limited Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Butorphanol Product Portfolios and Specifications
13.3.3 Pfizer Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Apothecon Pharmaceuticals
13.4.1 Apothecon Pharmaceuticals Company Information
13.4.2 Apothecon Pharmaceuticals Butorphanol Product Portfolios and Specifications
13.4.3 Apothecon Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Apothecon Pharmaceuticals Main Business Overview
13.4.5 Apothecon Pharmaceuticals Latest Developments
13.5 Mylan
13.5.1 Mylan Company Information
13.5.2 Mylan Butorphanol Product Portfolios and Specifications
13.5.3 Mylan Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Mylan Main Business Overview
13.5.5 Mylan Latest Developments
13.6 Novex Pharma
13.6.1 Novex Pharma Company Information
13.6.2 Novex Pharma Butorphanol Product Portfolios and Specifications
13.6.3 Novex Pharma Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novex Pharma Main Business Overview
13.6.5 Novex Pharma Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Butorphanol Product Portfolios and Specifications
13.7.3 Bristol Myers Squibb Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Sanochemia Pharmazeutika
13.8.1 Sanochemia Pharmazeutika Company Information
13.8.2 Sanochemia Pharmazeutika Butorphanol Product Portfolios and Specifications
13.8.3 Sanochemia Pharmazeutika Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sanochemia Pharmazeutika Main Business Overview
13.8.5 Sanochemia Pharmazeutika Latest Developments
13.9 Selectavet
13.9.1 Selectavet Company Information
13.9.2 Selectavet Butorphanol Product Portfolios and Specifications
13.9.3 Selectavet Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Selectavet Main Business Overview
13.9.5 Selectavet Latest Developments
13.10 Richter Pharma Ag
13.10.1 Richter Pharma Ag Company Information
13.10.2 Richter Pharma Ag Butorphanol Product Portfolios and Specifications
13.10.3 Richter Pharma Ag Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Richter Pharma Ag Main Business Overview
13.10.5 Richter Pharma Ag Latest Developments
13.11 Troy Laboratories Nz
13.11.1 Troy Laboratories Nz Company Information
13.11.2 Troy Laboratories Nz Butorphanol Product Portfolios and Specifications
13.11.3 Troy Laboratories Nz Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Troy Laboratories Nz Main Business Overview
13.11.5 Troy Laboratories Nz Latest Developments
13.12 Animedica
13.12.1 Animedica Company Information
13.12.2 Animedica Butorphanol Product Portfolios and Specifications
13.12.3 Animedica Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Animedica Main Business Overview
13.12.5 Animedica Latest Developments
13.13 Boehringer Ingelheim Sant? Animale
13.13.1 Boehringer Ingelheim Sant? Animale Company Information
13.13.2 Boehringer Ingelheim Sant? Animale Butorphanol Product Portfolios and Specifications
13.13.3 Boehringer Ingelheim Sant? Animale Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Boehringer Ingelheim Sant? Animale Main Business Overview
13.13.5 Boehringer Ingelheim Sant? Animale Latest Developments
13.14 Ausrichter
13.14.1 Ausrichter Company Information
13.14.2 Ausrichter Butorphanol Product Portfolios and Specifications
13.14.3 Ausrichter Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ausrichter Main Business Overview
13.14.5 Ausrichter Latest Developments
13.15 Zoetis
13.15.1 Zoetis Company Information
13.15.2 Zoetis Butorphanol Product Portfolios and Specifications
13.15.3 Zoetis Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Zoetis Main Business Overview
13.15.5 Zoetis Latest Developments
13.16 Dechra Pharmaceuticals
13.16.1 Dechra Pharmaceuticals Company Information
13.16.2 Dechra Pharmaceuticals Butorphanol Product Portfolios and Specifications
13.16.3 Dechra Pharmaceuticals Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Dechra Pharmaceuticals Main Business Overview
13.16.5 Dechra Pharmaceuticals Latest Developments
13.17 Faunapharma
13.17.1 Faunapharma Company Information
13.17.2 Faunapharma Butorphanol Product Portfolios and Specifications
13.17.3 Faunapharma Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Faunapharma Main Business Overview
13.17.5 Faunapharma Latest Developments
13.18 Merck KGaA
13.18.1 Merck KGaA Company Information
13.18.2 Merck KGaA Butorphanol Product Portfolios and Specifications
13.18.3 Merck KGaA Butorphanol Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Merck KGaA Main Business Overview
13.18.5 Merck KGaA Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Butorphanol Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Butorphanol Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Spray
Table 4. Major Players of Injection
Table 5. Major Players of Tablet
Table 6. Global Butorphanol Sales by Type (2018-2023) & (K Units)
Table 7. Global Butorphanol Sales Market Share by Type (2018-2023)
Table 8. Global Butorphanol Revenue by Type (2018-2023) & ($ million)
Table 9. Global Butorphanol Revenue Market Share by Type (2018-2023)
Table 10. Global Butorphanol Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Butorphanol Sales by Application (2018-2023) & (K Units)
Table 12. Global Butorphanol Sales Market Share by Application (2018-2023)
Table 13. Global Butorphanol Revenue by Application (2018-2023)
Table 14. Global Butorphanol Revenue Market Share by Application (2018-2023)
Table 15. Global Butorphanol Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Butorphanol Sales by Company (2018-2023) & (K Units)
Table 17. Global Butorphanol Sales Market Share by Company (2018-2023)
Table 18. Global Butorphanol Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Butorphanol Revenue Market Share by Company (2018-2023)
Table 20. Global Butorphanol Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Butorphanol Producing Area Distribution and Sales Area
Table 22. Players Butorphanol Products Offered
Table 23. Butorphanol Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Butorphanol Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Butorphanol Sales Market Share Geographic Region (2018-2023)
Table 28. Global Butorphanol Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Butorphanol Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Butorphanol Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Butorphanol Sales Market Share by Country/Region (2018-2023)
Table 32. Global Butorphanol Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Butorphanol Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Butorphanol Sales by Country (2018-2023) & (K Units)
Table 35. Americas Butorphanol Sales Market Share by Country (2018-2023)
Table 36. Americas Butorphanol Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Butorphanol Revenue Market Share by Country (2018-2023)
Table 38. Americas Butorphanol Sales by Type (2018-2023) & (K Units)
Table 39. Americas Butorphanol Sales by Application (2018-2023) & (K Units)
Table 40. APAC Butorphanol Sales by Region (2018-2023) & (K Units)
Table 41. APAC Butorphanol Sales Market Share by Region (2018-2023)
Table 42. APAC Butorphanol Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Butorphanol Revenue Market Share by Region (2018-2023)
Table 44. APAC Butorphanol Sales by Type (2018-2023) & (K Units)
Table 45. APAC Butorphanol Sales by Application (2018-2023) & (K Units)
Table 46. Europe Butorphanol Sales by Country (2018-2023) & (K Units)
Table 47. Europe Butorphanol Sales Market Share by Country (2018-2023)
Table 48. Europe Butorphanol Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Butorphanol Revenue Market Share by Country (2018-2023)
Table 50. Europe Butorphanol Sales by Type (2018-2023) & (K Units)
Table 51. Europe Butorphanol Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Butorphanol Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Butorphanol Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Butorphanol Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Butorphanol Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Butorphanol Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Butorphanol Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Butorphanol
Table 59. Key Market Challenges & Risks of Butorphanol
Table 60. Key Industry Trends of Butorphanol
Table 61. Butorphanol Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Butorphanol Distributors List
Table 64. Butorphanol Customer List
Table 65. Global Butorphanol Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Butorphanol Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Butorphanol Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Butorphanol Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Butorphanol Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Butorphanol Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Butorphanol Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Butorphanol Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Butorphanol Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Butorphanol Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Butorphanol Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Butorphanol Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Butorphanol Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Butorphanol Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Hikma Pharmaceuticals Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 80. Hikma Pharmaceuticals Butorphanol Product Portfolios and Specifications
Table 81. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Hikma Pharmaceuticals Main Business
Table 83. Hikma Pharmaceuticals Latest Developments
Table 84. Athanas Enterprise Private Limited Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 85. Athanas Enterprise Private Limited Butorphanol Product Portfolios and Specifications
Table 86. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Athanas Enterprise Private Limited Main Business
Table 88. Athanas Enterprise Private Limited Latest Developments
Table 89. Pfizer Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Butorphanol Product Portfolios and Specifications
Table 91. Pfizer Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Apothecon Pharmaceuticals Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 95. Apothecon Pharmaceuticals Butorphanol Product Portfolios and Specifications
Table 96. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Apothecon Pharmaceuticals Main Business
Table 98. Apothecon Pharmaceuticals Latest Developments
Table 99. Mylan Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Butorphanol Product Portfolios and Specifications
Table 101. Mylan Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Novex Pharma Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 105. Novex Pharma Butorphanol Product Portfolios and Specifications
Table 106. Novex Pharma Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Novex Pharma Main Business
Table 108. Novex Pharma Latest Developments
Table 109. Bristol Myers Squibb Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol Myers Squibb Butorphanol Product Portfolios and Specifications
Table 111. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bristol Myers Squibb Main Business
Table 113. Bristol Myers Squibb Latest Developments
Table 114. Sanochemia Pharmazeutika Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanochemia Pharmazeutika Butorphanol Product Portfolios and Specifications
Table 116. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Sanochemia Pharmazeutika Main Business
Table 118. Sanochemia Pharmazeutika Latest Developments
Table 119. Selectavet Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 120. Selectavet Butorphanol Product Portfolios and Specifications
Table 121. Selectavet Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Selectavet Main Business
Table 123. Selectavet Latest Developments
Table 124. Richter Pharma Ag Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 125. Richter Pharma Ag Butorphanol Product Portfolios and Specifications
Table 126. Richter Pharma Ag Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Richter Pharma Ag Main Business
Table 128. Richter Pharma Ag Latest Developments
Table 129. Troy Laboratories Nz Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 130. Troy Laboratories Nz Butorphanol Product Portfolios and Specifications
Table 131. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Troy Laboratories Nz Main Business
Table 133. Troy Laboratories Nz Latest Developments
Table 134. Animedica Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 135. Animedica Butorphanol Product Portfolios and Specifications
Table 136. Animedica Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Animedica Main Business
Table 138. Animedica Latest Developments
Table 139. Boehringer Ingelheim Sant? Animale Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 140. Boehringer Ingelheim Sant? Animale Butorphanol Product Portfolios and Specifications
Table 141. Boehringer Ingelheim Sant? Animale Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Boehringer Ingelheim Sant? Animale Main Business
Table 143. Boehringer Ingelheim Sant? Animale Latest Developments
Table 144. Ausrichter Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 145. Ausrichter Butorphanol Product Portfolios and Specifications
Table 146. Ausrichter Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Ausrichter Main Business
Table 148. Ausrichter Latest Developments
Table 149. Zoetis Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 150. Zoetis Butorphanol Product Portfolios and Specifications
Table 151. Zoetis Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Zoetis Main Business
Table 153. Zoetis Latest Developments
Table 154. Dechra Pharmaceuticals Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 155. Dechra Pharmaceuticals Butorphanol Product Portfolios and Specifications
Table 156. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Dechra Pharmaceuticals Main Business
Table 158. Dechra Pharmaceuticals Latest Developments
Table 159. Faunapharma Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 160. Faunapharma Butorphanol Product Portfolios and Specifications
Table 161. Faunapharma Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Faunapharma Main Business
Table 163. Faunapharma Latest Developments
Table 164. Merck KGaA Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 165. Merck KGaA Butorphanol Product Portfolios and Specifications
Table 166. Merck KGaA Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Merck KGaA Main Business
Table 168. Merck KGaA Latest Developments
Table 1. Butorphanol Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Butorphanol Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Spray
Table 4. Major Players of Injection
Table 5. Major Players of Tablet
Table 6. Global Butorphanol Sales by Type (2018-2023) & (K Units)
Table 7. Global Butorphanol Sales Market Share by Type (2018-2023)
Table 8. Global Butorphanol Revenue by Type (2018-2023) & ($ million)
Table 9. Global Butorphanol Revenue Market Share by Type (2018-2023)
Table 10. Global Butorphanol Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Butorphanol Sales by Application (2018-2023) & (K Units)
Table 12. Global Butorphanol Sales Market Share by Application (2018-2023)
Table 13. Global Butorphanol Revenue by Application (2018-2023)
Table 14. Global Butorphanol Revenue Market Share by Application (2018-2023)
Table 15. Global Butorphanol Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Butorphanol Sales by Company (2018-2023) & (K Units)
Table 17. Global Butorphanol Sales Market Share by Company (2018-2023)
Table 18. Global Butorphanol Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Butorphanol Revenue Market Share by Company (2018-2023)
Table 20. Global Butorphanol Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Butorphanol Producing Area Distribution and Sales Area
Table 22. Players Butorphanol Products Offered
Table 23. Butorphanol Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Butorphanol Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Butorphanol Sales Market Share Geographic Region (2018-2023)
Table 28. Global Butorphanol Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Butorphanol Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Butorphanol Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Butorphanol Sales Market Share by Country/Region (2018-2023)
Table 32. Global Butorphanol Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Butorphanol Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Butorphanol Sales by Country (2018-2023) & (K Units)
Table 35. Americas Butorphanol Sales Market Share by Country (2018-2023)
Table 36. Americas Butorphanol Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Butorphanol Revenue Market Share by Country (2018-2023)
Table 38. Americas Butorphanol Sales by Type (2018-2023) & (K Units)
Table 39. Americas Butorphanol Sales by Application (2018-2023) & (K Units)
Table 40. APAC Butorphanol Sales by Region (2018-2023) & (K Units)
Table 41. APAC Butorphanol Sales Market Share by Region (2018-2023)
Table 42. APAC Butorphanol Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Butorphanol Revenue Market Share by Region (2018-2023)
Table 44. APAC Butorphanol Sales by Type (2018-2023) & (K Units)
Table 45. APAC Butorphanol Sales by Application (2018-2023) & (K Units)
Table 46. Europe Butorphanol Sales by Country (2018-2023) & (K Units)
Table 47. Europe Butorphanol Sales Market Share by Country (2018-2023)
Table 48. Europe Butorphanol Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Butorphanol Revenue Market Share by Country (2018-2023)
Table 50. Europe Butorphanol Sales by Type (2018-2023) & (K Units)
Table 51. Europe Butorphanol Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Butorphanol Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Butorphanol Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Butorphanol Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Butorphanol Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Butorphanol Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Butorphanol Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Butorphanol
Table 59. Key Market Challenges & Risks of Butorphanol
Table 60. Key Industry Trends of Butorphanol
Table 61. Butorphanol Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Butorphanol Distributors List
Table 64. Butorphanol Customer List
Table 65. Global Butorphanol Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Butorphanol Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Butorphanol Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Butorphanol Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Butorphanol Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Butorphanol Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Butorphanol Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Butorphanol Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Butorphanol Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Butorphanol Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Butorphanol Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Butorphanol Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Butorphanol Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Butorphanol Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Hikma Pharmaceuticals Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 80. Hikma Pharmaceuticals Butorphanol Product Portfolios and Specifications
Table 81. Hikma Pharmaceuticals Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Hikma Pharmaceuticals Main Business
Table 83. Hikma Pharmaceuticals Latest Developments
Table 84. Athanas Enterprise Private Limited Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 85. Athanas Enterprise Private Limited Butorphanol Product Portfolios and Specifications
Table 86. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Athanas Enterprise Private Limited Main Business
Table 88. Athanas Enterprise Private Limited Latest Developments
Table 89. Pfizer Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Butorphanol Product Portfolios and Specifications
Table 91. Pfizer Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Apothecon Pharmaceuticals Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 95. Apothecon Pharmaceuticals Butorphanol Product Portfolios and Specifications
Table 96. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Apothecon Pharmaceuticals Main Business
Table 98. Apothecon Pharmaceuticals Latest Developments
Table 99. Mylan Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Butorphanol Product Portfolios and Specifications
Table 101. Mylan Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Novex Pharma Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 105. Novex Pharma Butorphanol Product Portfolios and Specifications
Table 106. Novex Pharma Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Novex Pharma Main Business
Table 108. Novex Pharma Latest Developments
Table 109. Bristol Myers Squibb Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol Myers Squibb Butorphanol Product Portfolios and Specifications
Table 111. Bristol Myers Squibb Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bristol Myers Squibb Main Business
Table 113. Bristol Myers Squibb Latest Developments
Table 114. Sanochemia Pharmazeutika Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 115. Sanochemia Pharmazeutika Butorphanol Product Portfolios and Specifications
Table 116. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Sanochemia Pharmazeutika Main Business
Table 118. Sanochemia Pharmazeutika Latest Developments
Table 119. Selectavet Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 120. Selectavet Butorphanol Product Portfolios and Specifications
Table 121. Selectavet Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Selectavet Main Business
Table 123. Selectavet Latest Developments
Table 124. Richter Pharma Ag Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 125. Richter Pharma Ag Butorphanol Product Portfolios and Specifications
Table 126. Richter Pharma Ag Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Richter Pharma Ag Main Business
Table 128. Richter Pharma Ag Latest Developments
Table 129. Troy Laboratories Nz Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 130. Troy Laboratories Nz Butorphanol Product Portfolios and Specifications
Table 131. Troy Laboratories Nz Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Troy Laboratories Nz Main Business
Table 133. Troy Laboratories Nz Latest Developments
Table 134. Animedica Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 135. Animedica Butorphanol Product Portfolios and Specifications
Table 136. Animedica Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Animedica Main Business
Table 138. Animedica Latest Developments
Table 139. Boehringer Ingelheim Sant? Animale Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 140. Boehringer Ingelheim Sant? Animale Butorphanol Product Portfolios and Specifications
Table 141. Boehringer Ingelheim Sant? Animale Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Boehringer Ingelheim Sant? Animale Main Business
Table 143. Boehringer Ingelheim Sant? Animale Latest Developments
Table 144. Ausrichter Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 145. Ausrichter Butorphanol Product Portfolios and Specifications
Table 146. Ausrichter Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Ausrichter Main Business
Table 148. Ausrichter Latest Developments
Table 149. Zoetis Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 150. Zoetis Butorphanol Product Portfolios and Specifications
Table 151. Zoetis Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Zoetis Main Business
Table 153. Zoetis Latest Developments
Table 154. Dechra Pharmaceuticals Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 155. Dechra Pharmaceuticals Butorphanol Product Portfolios and Specifications
Table 156. Dechra Pharmaceuticals Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Dechra Pharmaceuticals Main Business
Table 158. Dechra Pharmaceuticals Latest Developments
Table 159. Faunapharma Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 160. Faunapharma Butorphanol Product Portfolios and Specifications
Table 161. Faunapharma Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Faunapharma Main Business
Table 163. Faunapharma Latest Developments
Table 164. Merck KGaA Basic Information, Butorphanol Manufacturing Base, Sales Area and Its Competitors
Table 165. Merck KGaA Butorphanol Product Portfolios and Specifications
Table 166. Merck KGaA Butorphanol Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Merck KGaA Main Business
Table 168. Merck KGaA Latest Developments
LIST OF FIGURES
Figure 1. Picture of Butorphanol
Figure 2. Butorphanol Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Butorphanol Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Butorphanol Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Butorphanol Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Spray
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Tablet
Figure 12. Global Butorphanol Sales Market Share by Type in 2022
Figure 13. Global Butorphanol Revenue Market Share by Type (2018-2023)
Figure 14. Butorphanol Consumed in Human
Figure 15. Global Butorphanol Market: Human (2018-2023) & (K Units)
Figure 16. Butorphanol Consumed in Veterinary
Figure 17. Global Butorphanol Market: Veterinary (2018-2023) & (K Units)
Figure 18. Global Butorphanol Sales Market Share by Application (2022)
Figure 19. Global Butorphanol Revenue Market Share by Application in 2022
Figure 20. Butorphanol Sales Market by Company in 2022 (K Units)
Figure 21. Global Butorphanol Sales Market Share by Company in 2022
Figure 22. Butorphanol Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Butorphanol Revenue Market Share by Company in 2022
Figure 24. Global Butorphanol Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Butorphanol Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Butorphanol Sales 2018-2023 (K Units)
Figure 27. Americas Butorphanol Revenue 2018-2023 ($ Millions)
Figure 28. APAC Butorphanol Sales 2018-2023 (K Units)
Figure 29. APAC Butorphanol Revenue 2018-2023 ($ Millions)
Figure 30. Europe Butorphanol Sales 2018-2023 (K Units)
Figure 31. Europe Butorphanol Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Butorphanol Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Butorphanol Revenue 2018-2023 ($ Millions)
Figure 34. Americas Butorphanol Sales Market Share by Country in 2022
Figure 35. Americas Butorphanol Revenue Market Share by Country in 2022
Figure 36. Americas Butorphanol Sales Market Share by Type (2018-2023)
Figure 37. Americas Butorphanol Sales Market Share by Application (2018-2023)
Figure 38. United States Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Butorphanol Sales Market Share by Region in 2022
Figure 43. APAC Butorphanol Revenue Market Share by Regions in 2022
Figure 44. APAC Butorphanol Sales Market Share by Type (2018-2023)
Figure 45. APAC Butorphanol Sales Market Share by Application (2018-2023)
Figure 46. China Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Butorphanol Sales Market Share by Country in 2022
Figure 54. Europe Butorphanol Revenue Market Share by Country in 2022
Figure 55. Europe Butorphanol Sales Market Share by Type (2018-2023)
Figure 56. Europe Butorphanol Sales Market Share by Application (2018-2023)
Figure 57. Germany Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Butorphanol Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Butorphanol Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Butorphanol Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Butorphanol Sales Market Share by Application (2018-2023)
Figure 66. Egypt Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Butorphanol in 2022
Figure 72. Manufacturing Process Analysis of Butorphanol
Figure 73. Industry Chain Structure of Butorphanol
Figure 74. Channels of Distribution
Figure 75. Global Butorphanol Sales Market Forecast by Region (2024-2029)
Figure 76. Global Butorphanol Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Butorphanol Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Butorphanol Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Butorphanol Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Butorphanol Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Butorphanol
Figure 2. Butorphanol Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Butorphanol Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Butorphanol Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Butorphanol Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Spray
Figure 10. Product Picture of Injection
Figure 11. Product Picture of Tablet
Figure 12. Global Butorphanol Sales Market Share by Type in 2022
Figure 13. Global Butorphanol Revenue Market Share by Type (2018-2023)
Figure 14. Butorphanol Consumed in Human
Figure 15. Global Butorphanol Market: Human (2018-2023) & (K Units)
Figure 16. Butorphanol Consumed in Veterinary
Figure 17. Global Butorphanol Market: Veterinary (2018-2023) & (K Units)
Figure 18. Global Butorphanol Sales Market Share by Application (2022)
Figure 19. Global Butorphanol Revenue Market Share by Application in 2022
Figure 20. Butorphanol Sales Market by Company in 2022 (K Units)
Figure 21. Global Butorphanol Sales Market Share by Company in 2022
Figure 22. Butorphanol Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Butorphanol Revenue Market Share by Company in 2022
Figure 24. Global Butorphanol Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Butorphanol Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Butorphanol Sales 2018-2023 (K Units)
Figure 27. Americas Butorphanol Revenue 2018-2023 ($ Millions)
Figure 28. APAC Butorphanol Sales 2018-2023 (K Units)
Figure 29. APAC Butorphanol Revenue 2018-2023 ($ Millions)
Figure 30. Europe Butorphanol Sales 2018-2023 (K Units)
Figure 31. Europe Butorphanol Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Butorphanol Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Butorphanol Revenue 2018-2023 ($ Millions)
Figure 34. Americas Butorphanol Sales Market Share by Country in 2022
Figure 35. Americas Butorphanol Revenue Market Share by Country in 2022
Figure 36. Americas Butorphanol Sales Market Share by Type (2018-2023)
Figure 37. Americas Butorphanol Sales Market Share by Application (2018-2023)
Figure 38. United States Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Butorphanol Sales Market Share by Region in 2022
Figure 43. APAC Butorphanol Revenue Market Share by Regions in 2022
Figure 44. APAC Butorphanol Sales Market Share by Type (2018-2023)
Figure 45. APAC Butorphanol Sales Market Share by Application (2018-2023)
Figure 46. China Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Butorphanol Sales Market Share by Country in 2022
Figure 54. Europe Butorphanol Revenue Market Share by Country in 2022
Figure 55. Europe Butorphanol Sales Market Share by Type (2018-2023)
Figure 56. Europe Butorphanol Sales Market Share by Application (2018-2023)
Figure 57. Germany Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Butorphanol Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Butorphanol Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Butorphanol Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Butorphanol Sales Market Share by Application (2018-2023)
Figure 66. Egypt Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Butorphanol Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Butorphanol in 2022
Figure 72. Manufacturing Process Analysis of Butorphanol
Figure 73. Industry Chain Structure of Butorphanol
Figure 74. Channels of Distribution
Figure 75. Global Butorphanol Sales Market Forecast by Region (2024-2029)
Figure 76. Global Butorphanol Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Butorphanol Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Butorphanol Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Butorphanol Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Butorphanol Revenue Market Share Forecast by Application (2024-2029)
More Publications
Global Food Allergen ELISA Kits Market Growth (Status and Outlook) 2023-2029
US$ 3,660.00
February 2023
113 pages
Global Veterinary Ultrasound Systems Market Growth 2025-2031
US$ 3,660.00
December 2024
108 pages
Global Liposomal Paclitaxel Market Growth 2024-2030
US$ 3,660.00
September 2024
82 pages
Global Tele-ICU Services Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
89 pages
